Profile
Jacob J.
Clement joined MIGENIX, Inc. in August 2002.
He is Chief Science Officer and Senior Vice President-Science and Technology for MIGENIX.
Previously, he held various executive and senior management positions with Abbott Laboratories, Scriptgen Pharmaceuticals and Essential Therapeutics.
Dr. Clement received a PhD and a MSPH from the University of North Carolina, an MS degree from Roosevelt University and a BA degree from St. Mary's University.
Former positions of Jacob J. Clement
| Companies | Position | End |
|---|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Chief Tech/Sci/R&D Officer | 30/01/2009 |
Training of Jacob J. Clement
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Roosevelt University
Roosevelt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Mary's University
Saint Mary's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jacob J. Clement
















